Locations:
Search IconSearch
December 3, 2021/Pediatrics/Neurosurgery

Study Examines Outcomes of ‘Ultra Early’ Epilepsy Surgery

Cleveland Clinic authors contribute to large epilespy surgery study

21-CHP-2529943 CQD 650×450

Drug-resistant epilepsy (DRE) is often a devastating disease when it begins in infancy.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

While some infants are surgical candidates for brain surgery, which can be a life-altering intervention, most are not referred to a specialized center in time. This is due to a myriad of reasons, including lack of education about options, access, fear of brain surgery, and fruitless anti-seizure poly-therapy trials.

A delay in treatment often leads to epileptic encephalopathy with loss of critical developmental window in an infant’s development. The authors of a new study, published in Epilepsia, set out to review the safety and efficacy of “ultra-early” epilepsy surgery. Ajay Gupta, MD, Section Head of Pediatric Epilepsy at Cleveland Clinic Children’s, is a coauthor on this study.

Findings: At a glance

In this multicenter and multinational collaboration, the authors demonstrated safety and efficacy of epilepsy surgery in the youngest children, infants < 3 months of age. The study shows that epilepsy surgery was not only the most effective treatment leading to seizure remission in 66% of the infants with DRE but also it was safe in the hands of experienced surgeons and dedicated centers with no death or major unexpected long-term morbidity.

Cleveland Clinic’s Pediatric Epilepsy program

Cleveland Clinic’s Pediatric Epilepsy program contributed one of the largest cohorts in this paper as a result of the highly specialized, experienced and collaborative care across pediatric epilepsy, neurosurgery, intensive care, anesthesia, and pediatric subspecialty consultation teams that are critical to good outcomes in this sick and vulnerable patient population.

Advertisement

Reference

Roth J, Constantini S, Ekstein M, Weiner HL, Tripathi M, Chandra PS, Cossu M, Rizzi M, Bollo RJ, Machado HR, Santos MV, Keating RF, Oluigbo CO, Rutka JT, Drake JM, Jallo GI, Shimony N, Treiber JM, Consales A, Mangano FT, Wisoff JH, Teresa Hidalgo E, Bingaman WE, Gupta A, Erdemir G, Sundar SJ, Benifla M, Shapira V, Lam SK, Fallah A, Maniquis CAB, Tisdall M, Chari A, Cinalli G, Blount JP, Dorfmüller G, Christine Bulteau, Uliel-Sibony S. Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study. Epilepsia. 2021 Aug;62(8):1897-1906. doi: 10.1111/epi.16959. Epub 2021 Jun 14. PMID: 34128544.

Advertisement

Related Articles

Young boy using alternative communication device
November 26, 2024/Pediatrics/Rehabilitation
Communication Boards Transform Outpatient Therapy for Limited-Speaking Patients

Promoting inclusivity and accessibility for all children

Young woman talking with others in a circle
Roundtable Convenes to Improve Outcomes for Young Adults With IBD

Patients, caregivers and healthcare partners explore challenges during key transition points in care

Child with mom sitting on couch with hands on the child's stomach
What Triggers ‘Indeterminate’ Acute Liver Failure in Children?

Findings are first to provide underlying explanation, linking the diagnosis to high-immune activation and worse clinical outcomes

Two physicians standing at the end of the hallway talking
Subspecialty Consultation Patterns in Pediatric Hospital Medicine

Research aims to understand factors to help standardize practices

Adolescent patient sitting on hospital bed while provider uses stethoscope
October 3, 2024/Pediatrics/Cardiology
1 in 10 Children Will Experience Recurrent Rejection Following Heart Transplant

Results from a large registry study provide an updated picture of recurrent rejection

Pills scattered on table near bottle
Mounting Evidence Supports Sirolimus To Treat Capillary Lymphatic Venous Malformations

Data from combined prospective and retrospective cohorts support the drug’s safety and efficacy for CLVM

Ad